Say good-bye to mascara
Yesterday I blogged about drugs to make you smarter. Now here’s another I’m tempted to try. A treatment for glaucoma, it turns out, also makes your eyelashes grow. Last week an FDA’s expert advisory panel recommended that it be approved for that use.

The drug, known generically as brimatoprost, is made by the same company that makes Botox, Allergan Inc. It was first studied to help relieve eye pressure, but then the researchers noticed something totally unexpected: eyelash growth. The company is now seeking U.S. approval to market the new use under the brand name Latisse.
Some of the panelists raised concerns about long-term use and the lack of data on blacks and other minorities. The drug must be applied continuously or lashes will shrink to original size after a few months, according to the company.
Panelists also questioned whether teenagers and other patients might use it inappropriately, although the drug would only be available by prescription. There was no data on patients younger than 18.
The Latisse version will come with an applicator to apply drops on the edge of the eyelid, rather than into the eye as it is for glaucoma. Sales for eyelash growth could fetch more than $500 million globally per year, Allergan has said. Its total revenues were $3.9 billion in 2007.


